CBU
TARS icon

CIBC Bancorp USA’s Tarsus Pharmaceuticals TARS Stock Holding History

CIBC Bancorp USA’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$248K Buy
+4,175
New +$206K ﹤0.01% 1166

Other funds holding TARS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

CIBC Bancorp USA's TARS Position: Q3 2025 in Review

CIBC Bancorp USA opened a new position in Tarsus Pharmaceuticals (TARS) in Q3 2025: 4,175 shares worth $248K. The stake represents ﹤0.01% of the portfolio and ranks #1166 among its holdings.

220 funds tracked by Wall St. Rank hold TARS as of Q3 2025.

  • CIBC Bancorp USA held 4,175 shares of Tarsus Pharmaceuticals worth $248K as of Q3 2025.
  • Tarsus Pharmaceuticals was a new CIBC Bancorp USA position in Q3 2025.
  • Tarsus Pharmaceuticals made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q3 2025, its #1166 holding.
  • 220 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q3 2025.

Based on CIBC Bancorp USA's 13F filing for Q3 2025, filed 12 Nov 2025.